A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

Keyphrases

• Double-blind Trial 100%
• Postpartum Depression 100%
• Randomized Placebo-controlled Trial 100%
• Sertraline 100%
• Placebo 50%
• Depression Onset 50%
• Time Effect 33%
• Response Rate 33%
• Remission 33%
• DSM-IV 33%
• Group by 33%
• Clinical Global Impression 33%
• Hamilton Depression Rating Scale (HAM-D) 33%
• Childbirth 16%
• Major Depressive Disorder 16%
• Selective Serotonin Reuptake Inhibitors 16%
• Mixed Models 16%
• Continued Use 16%
• Remission Rate 16%
• Single Center 16%
• Placebo-controlled Study 16%
• Postpartum Women 16%
• Antidepressant Treatment 16%
• Specifier 16%
• DSM-5 16%
• Hamas 16%
• Hamilton Anxiety Rating Scale 16%
• Placebo Lead-in 16%

Medicine and Dentistry

• Postpartum Depression 100%
• Placebo 100%
• Sertraline 100%
• DSM-IV 33%
• Clinical Global Impression 33%
• Childbirth 16%
• Spontaneous Remission 16%
• Mixed Model 16%
• Placebo-Controlled Study 16%
• Child 16%
• Antidepressant 16%
• Major Depressive Episode 16%
• DSM-5 16%
• Selective Serotonin Reuptake Inhibitor 16%
• Hamilton Rating Scale for Depression 16%
• Hamilton Anxiety Rating Scale 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Sertraline 100%
• Postnatal Depression 100%
• Remission 50%
• DSM-IV 33%
• Placebo-Controlled Study 16%
• Selective Serotonin Reuptake Inhibitor 16%
• Major Depression 16%
• Antidepressant 16%
• Mixed Model 16%
• DSM-5 16%